NASDAQ
26.08.26 | 22:00
7,110 US-Dollar
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.08. | Profound Medical Corp (2): Profound introduces software for six Tulsa procedures | 1 | Stockwatch | ||
| 17.08. | Profound Medical Corp.: Profound's Introduction of New Real-time Interventional MRI Software Paving the Way for Full 'TULSA Days' | 1 | GlobeNewswire (USA) | ||
| 15.08. | Profound Medical Corp (2): Profound Medical appoints Sobczyk interim CFO | 1 | Stockwatch | ||
| 14.08. | Profound Medical names interim CFO | 1 | Seeking Alpha | ||
| 14.08. | Profound Medical Corp.: Profound Medical Announces Management Change | 200 | GlobeNewswire (Europe) | TORONTO, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets innovative... ► Artikel lesen | |
| 13.08. | Profound Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| PROFOUND MEDICAL Aktie jetzt für 0€ handeln | |||||
| 13.08. | Profound Medical Corp.: Profound Medical Launches 'Let's Huddle', a Global Community Supporting Men Throughout Their Prostate Care Journey | 1 | GlobeNewswire (USA) | ||
| 06.08. | Profound Medical GAAP EPS of -$0.26 misses by $0.02, revenue of $2.5M misses by $2.19M | 1 | Seeking Alpha | ||
| 06.08. | Profound Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.08. | Profound Medical Corp.: Profound Medical Reports Second Quarter 2026 Financial Results | 149 | GlobeNewswire (Europe) | - Operating expenses decline 16%, helping drive a 39% improvement in net loss - - Approximately $3.1 million of TULSA revenue recognition shifts into early Q3 due to shipment timing - - Strong clinical... ► Artikel lesen | |
| 27.07. | Profound Medical: Aktie nach Studiendaten und Erstattungsausblick auf "Strong Buy" hochgestuft | 1 | Investing.com Deutsch | ||
| 27.07. | Profound Medical stock upgraded to Strong Buy on trial data, reimbursement outlook | 1 | Investing.com | ||
| 24.07. | Profound Medical Corp (2): Profound finds no penile length change after Tulsa | 1 | Stockwatch | ||
| 24.07. | Profound Medical Corp. - 8-K, Current Report | - | SEC Filings | ||
| 24.07. | Profound Medical Corp.: Robotic Radical Prostatectomy Comes Up 'Short' in CAPTAIN Trial | 4 | GlobeNewswire (USA) | ||
| 17.07. | Profound Medical Corp (2): Profound Medical to release Q2 results on Aug. 6 | 1 | Stockwatch | ||
| 15.07. | Stocks in Play: Profound Medical Corp. | - | Baystreet.ca | ||
| 15.07. | Profound Medical Corp. - 8-K, Current Report | 2 | SEC Filings | ||
| 15.07. | Profound Medical Corp.: Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026 | 2 | GlobeNewswire (USA) | ||
| 22.06. | Profound Medical Corp. (PROF) Dropped Despite High Potential | 1 | Insider Monkey |
1 2 3 Weiter >>
53 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CERENOME | 2,540 | +0,40 % | Cerenome, Inc.: Cerenome Reports Second Quarter 2026 Financial Results and Business Update | HOUSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), a CNS oncology company advancing an integrated platform that combines precision diagnostics... ► Artikel lesen | |
| ORGANON | 11,785 | -0,25 % | Dividendenbekanntmachungen (14.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADM HAMBURG AG DE0007269003 - 13,58 EUR AGCO CORPORATION US0010841023 0,3 USD 0,2602 EUR AGNT INC US30212W1009 0,05 USD 0,0433... ► Artikel lesen | |
| QUIDELORTHO | 12,285 | -3,91 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| NANO-X IMAGING | 0,863 | -1,44 % | Nano-X Imaging Ltd: Nanox to Report Second Quarter 2026 Financial Results on September 9, 2026 | ||
| ROCKWELL MEDICAL | 8,140 | +2,84 % | XFRA RWM: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILROCKWELL MEDICAL... ► Artikel lesen | |
| NUWELLIS, INC | 1,000 | -0,99 % | Nuwellis, Inc. - 8-K, Current Report | ||
| PROCEPT BIOROBOTICS | 21,080 | +0,05 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| NEURONETICS | 2,490 | -2,73 % | Neuronetics Reports Second Quarter 2026 Financial and Operating Results | MALVERN, Pa., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the "Company" or "Neuronetics"), a leader in interventional mental health that combines its NeuroStar® TMS technology... ► Artikel lesen | |
| OPTIMIZERX | 7,750 | 0,00 % | OptimizeRx Corp - S-8, Securities to be offered to employees in employee benefit plans | ||
| OWLET | 5,180 | 0,00 % | Owlet: Hauptversammlung stimmt für Vergütungsplan und wählt Direktoren | ||
| ORTHOFIX MEDICAL | 8,000 | -1,84 % | Orthofix Medical Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| PAVMED | 4,355 | +6,87 % | PAVmed Inc.: PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results | Veris Health accelerated its commercial engagement with OSU-The James
Veris Health implantable physiological monitor achieved development milestones towards upcoming... ► Artikel lesen | |
| NEXGEL | 0,350 | -1,77 % | NEXGEL appoints Brian Kieser as interim CEO after Adam Levy steps down | ||
| PICARD MEDICAL | 9,585 | 0,00 % | Why Is Picard Medical Stock Gaining Monday? | ||
| QTREX QUANTUM | 0,820 | +0,18 % | QTREX Quantum nimmt 10 Millionen US-Dollar über Direktplatzierung ein |
Das Unternehmen PROFOUND MEDICAL CORP kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 7,110 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROFOUND MEDICAL CORP finden Sie auf Wallstreet Online.